Aminologics Co.Ltd Total Liabilities
Aminologics Co.Ltd total liabilities. Based on the latest financial reports, Aminologics Co.Ltd (074430) has total liabilities worth ₩31.28 Billion KRW (≈ $21.20 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Aminologics Co.Ltd's assets to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Aminologics Co.Ltd (2008–2025)
Total liabilities of Aminologics Co.Ltd from 2008 to 2025. This chart illustrates how Aminologics Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 074430 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Aminologics Co.Ltd Competitors by Total Liabilities
The table below lists competitors of Aminologics Co.Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Garo AB
ST:GARO
|
Sweden | Skr475.60 Million |
|
Adhi Commuter Properti Tbk PT
JK:ADCP
|
Indonesia | Rp4.35 Trillion |
|
Urbana Corporation
TO:URB
|
Canada | CA$94.46 Million |
|
ADYTON RESOURCES CORP.
F:701
|
Germany | €1.11 Million |
|
Hotel Mandarine Regency Tbk PT
JK:HOME
|
Indonesia | Rp334.09 Billion |
|
Shanghai Jin Jiang International Industrial Investment Co Ltd B
SHG:900914
|
China | $1.14 Billion |
|
Future Health Esg Corp
NASDAQ:FHLT
|
USA | $17.44 Million |
|
Ching Chan Optical Technology Co Ltd
TWO:2070
|
Taiwan | NT$574.88 Million |
Liability Composition Analysis (2008–2025)
This chart breaks down Aminologics Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Aminologics Co.Ltd (074430) total assets.
Liquidity & Leverage Metrics
Aminologics Co.Ltd Total Liabilities Ratios Explained
Aminologics Co.Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.28 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.54 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Aminologics Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Aminologics Co.Ltd (2008–2025)
The table below shows the annual total liabilities of Aminologics Co.Ltd from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩28.18 Billion ≈ $19.10 Million |
+453.31% |
| 2024-12-31 | ₩5.09 Billion ≈ $3.45 Million |
+56.39% |
| 2023-12-31 | ₩3.26 Billion ≈ $2.21 Million |
-22.04% |
| 2022-12-31 | ₩4.18 Billion ≈ $2.83 Million |
-28.57% |
| 2021-12-31 | ₩5.85 Billion ≈ $3.96 Million |
-10.98% |
| 2020-12-31 | ₩6.57 Billion ≈ $4.45 Million |
+10.95% |
| 2019-12-31 | ₩5.92 Billion ≈ $4.01 Million |
+61.32% |
| 2018-12-31 | ₩3.67 Billion ≈ $2.49 Million |
-13.19% |
| 2017-12-31 | ₩4.23 Billion ≈ $2.87 Million |
-5.56% |
| 2016-12-31 | ₩4.48 Billion ≈ $3.03 Million |
-33.68% |
| 2015-12-31 | ₩6.75 Billion ≈ $4.58 Million |
-0.47% |
| 2014-12-31 | ₩6.78 Billion ≈ $4.60 Million |
-12.81% |
| 2013-12-31 | ₩7.78 Billion ≈ $5.27 Million |
-63.30% |
| 2012-12-31 | ₩21.20 Billion ≈ $14.37 Million |
-7.42% |
| 2011-12-31 | ₩22.90 Billion ≈ $15.52 Million |
-3.59% |
| 2010-12-31 | ₩23.75 Billion ≈ $16.09 Million |
+72.46% |
| 2008-12-31 | ₩13.77 Billion ≈ $9.33 Million |
-- |
About Aminologics Co.Ltd
Aminologics Co.,Ltd., a specialty amino acid provider, develops a range of amino-acid-based raw materials for pharmaceutical and fine chemical industries in South Korea. Its products include D-phenylalanine, D-alanine, D-cysteine, D-serine, D-allo-isoleucine, D-allo-threonine, S-beta-phenylalanine, 3-(2-napthyl)-D-alanine, 4-chloro-D-phenylalanine, 3-(2-napthyl)-L-alanine, R-beta-phenylalanine, D… Read more